CPIX
Cumberland Pharmaceuticals Inc.
Drug Manufacturers - Specialty & Generic · Healthcare · United States
7.90
close · 2026-08-13
value
15
cheaper than peers15
quality
11
stronger fundamentals11
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
34 peerswide variation
Value inputs
| measure | company | vs peers |
| price to sales | 2.60× | 53 |
| price to book | 6.79× | 36 |
| EV to EBITDA | 103.62× | 10 |
| forward P/E | 56.43× | 2 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 27.6% | 84 |
| return on equity | -14.4% | 30 |
| revenue growth | -98.5% | 2 |
| operating margin | -1898.7% | 1 |
4 of 4 measures available
Facts
| market cap | $118M |
| free cash flow | -$310,025 |
| employees | 93 |
| first trade | 2009-08-11 |
| next earnings | 2026-08-04 |
| fundamentals updated | 2026-08-06 |